Cas:331240-54-1 (4-bromophenyl)-(2,3-dihydroindol-1-yl)methanone manufacturer & supplier

We serve Chemical Name:(4-bromophenyl)-(2,3-dihydroindol-1-yl)methanone CAS:331240-54-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(4-bromophenyl)-(2,3-dihydroindol-1-yl)methanone

Chemical Name:(4-bromophenyl)-(2,3-dihydroindol-1-yl)methanone
CAS.NO:331240-54-1
Synonyms:(4-bromophenyl)-(2,3-dihydroindol-1-yl)methanone
Molecular Formula:C15H12BrNO
Molecular Weight:302.16600
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:20.31000
Exact Mass:301.01000
LogP:3.71700

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (4-bromophenyl)-(2,3-dihydroindol-1-yl)methanone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(4-bromophenyl)-(2,3-dihydroindol-1-yl)methanone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(4-bromophenyl)-(2,3-dihydroindol-1-yl)methanone Use and application,(4-bromophenyl)-(2,3-dihydroindol-1-yl)methanone technical grade,usp/ep/jp grade.


Related News: Beneficial drug raw materials refer to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs). They are mainly used to meet the needs of original multinational pharmaceutical companies and emerging biopharmaceutical companies for innovative drugs in clinical drug research, registration approval and commercialization sales , Which also contains advanced intermediates used in the manufacture of the drug substance that need to be regulated by regulatory authorities. (4-bromophenyl)-(2,3-dihydroindol-1-yl)methanone manufacturer Catalent��s clinical supply network includes nine cGMP-certified clinical packaging facilities across North America, Europe and Asia, and more than 50 strategically-located depots around the world, providing local and regional options for clinical storage, distribution, expiry update and relabeling services, and clinical returns management. (4-bromophenyl)-(2,3-dihydroindol-1-yl)methanone supplier The continuous acceleration of the industrial transfer process has provided a huge market space for the fine chemical intermediate industry. (4-bromophenyl)-(2,3-dihydroindol-1-yl)methanone vendor These include: high-barrier generic drug substances and commonly used generic drug substances. (4-bromophenyl)-(2,3-dihydroindol-1-yl)methanone factory This includes chemical APIs.